"We have a lot to do, but it is exciting. Much of it is in our own hands," Sanofi CEO Paul Hudson said in his first briefing with US media since taking over the top leadership role at the French pharmaceutical company in September.
It's early days for Hudson, who is only one month into the job at Sanofi. Any big revelations around Hudson's near-term strategy or long-range vision for Sanofi will come later, toward the end of the year, after he has had more time to visit Sanofi's global R&D and manufacturing facilities
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?